Dermal Laboratories Ltd
Mark Briggs has extensive experience in quality assurance and compliance within the clinical and pharmacovigilance sectors. Currently serving as a Quality Assurance and Compliance Associate Clinical and Pharmacovigilance Auditor at Dermal Laboratories Limited since February 2018, Mark focuses on quality improvements and procedure development. Prior to this role, Mark held positions such as Senior Quality Assurance Auditor at GW Pharmaceuticals plc, where responsibilities included auditor training and site preparation for FDA and MHRA inspections. Mark's tenure at MedImmune included roles as CQA Associate Director and GCP Quality Compliance Manager, concentrating on organizing audits for vendors and investigator sites. Mark's career at GlaxoSmithKline spanned nearly 18 years as Clinical Manager, overseeing a team of Regional Clinical Study Managers and coordinating global clinical projects. Education was completed at Rhyl High School and Ysgol Llewelyn.
This person is not in any offices
Dermal Laboratories Ltd
Founded by a doctor in 1963, Dermal Laboratories, part of the family-owned Diomed Group, is one of the few truly independent UK pharmaceutical companies. For over 60 years we have focused on researching and developing innovative topical treatments primarily for prescription. A thorough understanding of the structure and biochemistry of the skin, the performance of the whole formulation, combined with recognising the concerns of healthcare professionals and the needs of patients, has been paramount in the design of Dermal’s topical treatments. This has led to significant advances in treatment through enhanced product efficacy and patient adherence. Dermal’s products are well known amongst Dermatologists, General Practitioners, Nurses and Pharmacists, and are widely prescribed for the treatment of a variety of skin disorders, as well as other conditions which can be treated by applied medication. A strong focus on excellence and reliability ensures we meet the highest standards of quality and performance while also prioritising sustainability and environmental responsibility.